As you know, maintaining compliance with industry standards is crucial for ensuring the safety and quality of sterile medicinal products. The recent updates to the European Union’s Good Manufacturing Practices (EU GMP) Annex 1 are no exception, introducing important changes that affect cleanroom operations.
Here’s a brief overview of what’s new in the revised Annex 1:
- Enhanced Risk Management: A stronger focus on Quality Risk Management (QRM) requires a systematic approach to controlling contamination risks.
- New Contamination Control Strategy (CCS): A detailed CCS is now mandatory, ensuring consistent quality across manufacturing processes.
- Acknowledging New Technologies: The updated guidelines recognise advancements like RABS and isolators, allowing for more efficient processes while maintaining safety.
These updates emphasise better risk management and advanced technology, helping ensure the highest standards of sterile medicinal production. At Cleanroom Connection, we are committed to helping you navigate these regulatory changes. Our wide selection of cleanroom supplies can support your efforts to remain compliant with the latest Annex 1 guidelines.
Feel free to reach out with any questions or visit our blog for more in-depth insights into these changes and how they might impact your operations.